Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients

NCT07510308 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

pMMR/MSS Advanced Colorectal Cancer

Interventions

BIOLOGICAL: Low Dose MSH2-/- tumor cell vaccine
BIOLOGICAL: Medium Dose MSH2-/- tumor cell vaccine
BIOLOGICAL: High dose MSH2-/- tumor cell vaccine

Sponsor

West China Hospital